Medtronic Stock Hits Day High with Strong 4.69% Intraday Surge

Medtronic Plc has experienced a notable uptick in its stock performance, gaining 4.69% on November 18, 2025. The stock reached an intraday high of USD 102.44, reflecting a strong day of trading for the large-cap company in the Pharmaceuticals & Biotechnology sector.
Over the past week, Medtronic has outperformed the S&P 500, with a weekly gain of 5.66% compared to the index's decline of 2.34%. The company's one-month performance also shows a positive trend, with a 5.24% increase against the S&P 500's slight gain of 0.13%. Year-to-date, Medtronic has delivered a robust return of 26.19%, significantly surpassing the S&P 500's 13.44%.

Key financial metrics indicate a solid operational foundation, with a low debt-to-equity ratio of 0.43 and a return on equity of 11.60%. The company has also reported strong operating cash flow, reaching USD 7,146 million, and a dividend per share of USD 5.57. With institutional holdings at 86.93%, Medtronic's stock reflects a stable investment environment, despite its underperformance relative to the market over the past year.